OPK
Opko Health Inc
1.40$
-4.8%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 17.4% | 15.4% | 19.8% | 18.1% | 27.9% | 30.1% | 34.7% | 29.6% | 31.4% | 30.1% | 28.8% | 27.3% | |
| 6.7% | 4.8% | 3.8% | 2.0% | 18.0% | 19.6% | 20.5% | 13.8% | 20.8% | 19.1% | 18.4% | 16.4% | |
| 6.7% | 4.8% | 3.8% | 2.0% | 18.0% | 19.6% | 20.5% | 13.8% | 20.8% | 19.1% | 18.4% | 16.4% | |
| 6.2% | 6.5% | 6.0% | 5.9% | 6.1% | 6.9% | 6.0% | 6.8% | 6.2% | 6.5% | 5.8% | 6.3% | |
| 3.4% | 3.3% | 3.0% | 3.0% | 2.6% | 2.6% | 3.0% | 3.4% | 3.3% | 3.4% | 3.5% | 3.4% | |
| 28.9% | 29.7% | 26.9% | 26.8% | 23.8% | 24.1% | 22.4% | 24.5% | 24.3% | 25.1% | 26.0% | 26.3% | |
| 46.4% | 46.5% | 44.3% | 43.1% | 28.4% | 36.9% | 35.9% | 38.1% | 36.6% | 26.7% | 37.2% | 26.1% | |
| 29.8% | 30.9% | 36.5% | 29.5% | 37.8% | 37.9% | 38.4% | 34.3% | 34.6% | 34.4% | 35.1% | 35.3% | |
| 9.8% | 9.9% | 10.4% | 11.1% | 9.4% | 8.8% | 13.9% | 8.7% | 8.5% | 7.6% | 8.0% | 8.2% | |
| 2.2% | 2.1% | 1.8% | 1.8% | 1.2% | 1.3% | 5.9% | 1.3% | 1.2% | 1.2% | 1.2% | 1.2% | |
| 3.2% | 3.5% | 3.6% | 4.2% | 2.8% | 2.1% | 2.8% | 2.9% | 2.5% | 2.1% | 2.4% | 2.7% | |
| 10.4% | 11.0% | 16.6% | 9.1% | 19.0% | 19.2% | 15.3% | 16.7% | 16.6% | 17.3% | 18.1% | 18.5% | |
| 70.2% | 69.1% | 63.5% | 70.5% | 62.2% | 62.1% | 61.6% | 65.7% | 65.4% | 65.6% | 64.9% | 64.7% | |
| -94.6% | -100.0% | -106.1% | -106.3% | -92.2% | -93.9% | -100.2% | -115.6% | -113.2% | -118.6% | -126.3% | -128.7% | |
| 36.5% | 37.4% | 35.8% | 35.2% | 30.8% | 31.5% | 31.6% | 39.9% | 39.1% | 39.6% | 40.9% | 41.3% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.